[Form 4] Eastman Chemical Company Insider Trading Activity

Rhea-AI Filing Summary

Insider purchase reported: Eastman Chemical Company director Kim Ann Mink purchased 1,450 shares of EMN common stock on 08/27/2025 at a price of $69.3799 per share. After the transaction she beneficially owned 2,840 shares. The Form 4 was signed by Mark D. Austin by power of attorney on 08/28/2025. No derivative transactions or other comments are reported in the filing.

Positive

• Director purchase disclosed: Reporting person acquired 1,450 shares at $69.3799, increasing ownership to 2,840 shares, enhancing transparency.
• Timely reporting: Form 4 filed and signed (08/28/2025) by power of attorney, meeting disclosure obligations.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: A director reported a small open-market purchase, indicating routine insider buying without additional disclosures.

The filing documents a direct purchase of 1,450 shares by a director at $69.3799, increasing reported beneficial ownership to 2,840 shares. The transaction was reported on a standard Form 4 with no derivatives or plan-based trades disclosed. This appears to be a routine, non-material insider purchase for a public company director.

Securities Analyst

TL;DR: Transaction is a straightforward director purchase; size appears modest relative to typical institutional holdings.

The purchase price and share count are clearly stated. There is no indication of transactions under a 10b5-1 plan or other arrangements in the form. The signed Form 4 satisfies Section 16 reporting requirements and provides transparency on a direct acquisition of common stock by an officer/director.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mink Kim Ann

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		1,450	A	$69.3799	2,840	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Kim Ann Mink	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Eastman Chemical (EMN) report on this Form 4?

The filing reports that director Kim Ann Mink purchased 1,450 shares of EMN common stock on 08/27/2025 at $69.3799 per share, resulting in 2,840 shares beneficially owned.

Was the Form 4 for EMN reporting any derivative transactions or 10b5-1 plan trades?

No. The Form 4 shows only a non-derivative common stock purchase and does not indicate derivative securities or an explicit 10b5-1 plan designation.

Who signed the EMN Form 4 and when was it signed?

The Form 4 was signed by Mark D. Austin by power of attorney for Kim Ann Mink on 08/28/2025.

How many shares did the reporting person own after the transaction?

After the reported purchase the reporting person beneficially owned 2,840 shares of EMN common stock.

What price was paid per share in the EMN insider purchase?

The reported purchase price was $69.3799 per share.